المختبرات الطبية الأولى

:Normal range

M: 0.42-3.5 ng/mL

F: *Follicular phase: 0.20-2.6 ng/mL

Luteal phase: 0.28-4.0 ng/mL*

Oral contraceptives: 0.09-1.7 ng/mL*

:Post-menopausal*

o        No hormone therapy: 0.11-1.2 ng/mL

o        With hormone therapy: 0.08-0.93 ng/mL

Comment: Used in the investigation of congenital adrenal hyperplasia. Increased in C-21-hydroxylase enzyme deficiency, some cases of ovarian or adrenal neoplasms, and in congenital adrenal hyperplasia. Decreased in Addison’s disease. Low levels of 17-hydroxyprogesteron lead to a decline in the levels of estrogens and androgens

Sample: Serum, early morning specimen (8-10 a.m.) preferred